Compound ID | 3202

Terizidone

Synonym(s): Terivalidin

Class: Oxazolidinone

Details of activity: Active against Mycobacterium tuberculosis; mycobacterial cell wall synthesis inhibitor (competitively binds L-alanine racemase and D-alanine ligase)
Description: Synthetic compound; cycloserine dimer; included in long treatment of MDR-TB but exhibits toxicity (second-line anti-TB drug)
Year first mentioned: 1965
Highest developmental phase: Phase 2/3 (NCT02454205)
Development status: Active (as of 2024)
Chemical structure(s):
Click here for structure editor
Molecular weight: 302.29
Iso. SMILES: C1C(C(=O)NO1)N=CC2=CC=C(C=C2)C=NC3CONC3=O
InChI Key: ODKYYBOHSVLGNU-UHFFFAOYSA-N
Can. SMILES: C1=C(C=CC(=C1)C=NC2CONC2=O)C=NC3CONC3=O
InChI: InChI=1S/C14H14N4O4/c19-13-11(7-21-17-13)15-5-9-1-2-10(4-3-9)6-16-12-8-22-18-14(12)20/h1-6,11-12H,7-8H2,(H,17,19)(H,18,20)

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.